Dr. Kelly Crotty is a Program Director in the Center for Strategic Scientific Initiatives (CSSI) at the National Cancer Institute (NCI). She directs the Innovative Molecular Analysis Technologies (IMAT) program, manages collaborative projects for the Informatics Technology for Cancer Research (ITCR) program, coordinates the COnsortium of METabolomics Studies (COMETS) program, and co-leads NCI's Emerging Technologies Seminar Series.
Dr. Crotty joined the National Cancer Institute in 2019 as an NCI Communications Fellow. She received her Ph.D. in biochemistry from the University of California – San Francisco where she used protein and RNA biochemical methods to investigate the Unfolded Protein Response across yeast species. In addition to her dissertation work, she organized an intramural seminar series at UCSF and volunteered with organizations supporting women and minorities in science.